Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients with Acquired Thrombotic Thrombocytopenic Purpura, PB2249HemaSphere. 2019 Jun;3(S1):1007. Sargentini L, Hansson E, Bergstrand M, Callewaert F, Sousa RP.HematologyJournalMIDDPharmacometricsSpecial/specific populationsPharmetheus Affiliates Senior Director, Regulatory AffairsEmma HanssonSee bio Principal Director, MIDD Scientific LeadMartin BergstrandSee bio
